ORCID as entered in ROS

Select Publications
2019, 'Efficacy and improvement of lipid profile after switching to rilpivirine in resource limited setting: real life clinical practice', AIDS Research and Therapy, 16, http://dx.doi.org/10.1186/s12981-019-0222-6
,2019, 'Where latest advances in HIV are shared: 21st Bangkok International Symposium on HIV Medicine', Future Virology, 14, pp. 129 - 132, http://dx.doi.org/10.2217/fvl-2019-0012
,2019, 'Diabetes mellitus burden among people living with HIV from the Asia-Pacific region', Journal of the International AIDS Society, 22, http://dx.doi.org/10.1002/jia2.25236
,2018, 'CD4/CD8 ratio normalization rates and low ratio as prognostic marker for non-AIDS defining events among long-term virologically suppressed people living with HIV NCT00411983 NCT', AIDS Research and Therapy, 15, http://dx.doi.org/10.1186/s12981-018-0200-4
,2018, 'HIV medicine as double-sided sword: Care and prevention', in Future Virology, pp. 313 - 316, http://dx.doi.org/10.2217/fvl-2018-0017
,2018, 'Coronary artery calcium (CAC) scores among long-term virologically suppressed non-diabetic HIV-infected elderly Asians', in ANTIVIRAL THERAPY, SAGE PUBLICATIONS LTD, pp. A10 - A10
,2024, 'Association of PNPLA3 rs738409 genotype with hepatic steatosis among non-obese people living with HIV', in Journal of the International AIDS Society, Wiley, Munich, Germany & Virtual, Vol. 27, pp. 22 - 22, presented at AIDS 2024, the 25th International AIDS Conference, Munich, Germany & Virtual, 22 July 2024, https://doi.org/10.1002/jia2.26279
,2023, Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia, http://dx.doi.org/10.1101/2023.08.17.23293358
,